Clinical trial
Testosterone and Physical Function in HIV+ Men
NCT00260143 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00260143 |
|---|---|
| Title | Testosterone and Physical Function in HIV+ Men |
| Official title | Testosterone and Physical Function in HIV Associate Weight Loss |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Charles Drew University of Medicine and Science |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Associate Weight Loss |
| Intervention type | Drug |
| Interventions | Testosterone enanthate, Placebo |
| Enrollment | 61 |
| Start date | May 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Dec 1, 2005 |
| Last update posted | Mar 9, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: